Apollo Endosurgery, Inc. (APEN): Price and Financial Metrics
GET POWR RATINGS... FREE!
APEN POWR Grades
- APEN scores best on the Sentiment dimension, with a Sentiment rank ahead of 66.01% of US stocks.
- APEN's strongest trending metric is Value; it's been moving down over the last 155 days.
- APEN ranks lowest in Momentum; there it ranks in the 13th percentile.
APEN Stock Summary
- APEN's price/sales ratio is 5.75; that's higher than the P/S ratio of 81.88% of US stocks.
- Over the past twelve months, APEN has reported earnings growth of 167.81%, putting it ahead of 91.25% of US stocks in our set.
- The volatility of APOLLO ENDOSURGERY INC's share price is greater than that of 84.96% US stocks with at least 200 days of trading history.
- Stocks that are quantitatively similar to APEN, based on their financial statements, market capitalization, and price volatility, are BDSX, SGHT, EKSO, PHUN, and KTOS.
- Visit APEN's SEC page to see the company's official filings. To visit the company's web site, go to www.apolloendo.com.
APEN Valuation Summary
- In comparison to the median Healthcare stock, APEN's price/sales ratio is 205.26% higher, now standing at 5.8.
- APEN's price/sales ratio has moved down 121.3 over the prior 194 months.
Below are key valuation metrics over time for APEN.
| Stock | Date | P/S | P/B | P/E | EV/EBIT |
|---|---|---|---|---|---|
| APEN | 2023-03-24 | 5.8 | 9.8 | -10.1 | -12.3 |
| APEN | 2023-03-23 | 5.7 | 9.7 | -10.1 | -12.2 |
| APEN | 2023-03-22 | 5.7 | 9.7 | -10.1 | -12.2 |
| APEN | 2023-03-21 | 5.8 | 9.8 | -10.2 | -12.3 |
| APEN | 2023-03-20 | 5.8 | 9.8 | -10.2 | -12.3 |
| APEN | 2023-03-17 | 5.7 | 9.7 | -10.1 | -12.2 |
APEN Growth Metrics
- The 3 year price growth rate now stands at 32.46%.
- Its 2 year price growth rate is now at 164.92%.
- Its 3 year cash and equivalents growth rate is now at 166.97%.
The table below shows APEN's growth in key financial areas (numbers in millions of US dollars).
| Date | Revenue | Operating Cash Flow | Net Income to Common Stock |
|---|---|---|---|
| 2022-09-30 | 71.713 | -25.298 | -40.691 |
| 2022-06-30 | 68.491 | -22.808 | -35.902 |
| 2022-03-31 | 65.794 | -18.834 | -28.495 |
| 2021-12-31 | 62.989 | -14.454 | -24.682 |
| 2021-09-30 | 59.678 | -12.91 | -17.782 |
| 2021-06-30 | 56.153 | -13.949 | -13.722 |
APEN's Quality Factors
The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.- APEN has a Quality Grade of D, ranking ahead of 22.64% of graded US stocks.
- APEN's asset turnover comes in at 0.804 -- ranking 36th of 186 Medical Equipment stocks.
- IDXG, BSGM, and ISR are the stocks whose asset turnover ratios are most correlated with APEN.
The table below shows APEN's key quality metrics over time.
| Period | Asset Turnover | Gross Margin | ROIC |
|---|---|---|---|
| 2021-09-30 | 0.804 | 0.554 | -0.164 |
| 2021-06-30 | 0.733 | 0.549 | -0.111 |
| 2021-03-31 | 0.619 | 0.534 | -0.161 |
| 2020-12-31 | 0.590 | 0.529 | -0.288 |
| 2020-09-30 | 0.584 | 0.507 | -0.429 |
| 2020-06-30 | 0.555 | 0.488 | -0.560 |
APEN Price Target
For more insight on analysts targets of APEN, see our APEN price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.
| Average Price Target | $14.00 | Average Broker Recommendation | 1.38 (Strong Buy) |
APEN Stock Price Chart Interactive Chart >
APEN Price/Volume Stats
| Current price | $9.91 | 52-week high | $10.30 |
| Prev. close | $9.92 | 52-week low | $3.49 |
| Day low | $9.91 | Volume | 510,756 |
| Day high | $9.93 | Avg. volume | 1,478,202 |
| 50-day MA | $9.91 | Dividend yield | N/A |
| 200-day MA | $7.31 | Market Cap | 471.21M |
Apollo Endosurgery, Inc. (APEN) Company Bio
Apollo Endosurgery, Inc. focuses on the design, development, and commercialization of medical devices for the treatment of obesity. The company offers endo-bariatric products, such as Orbera intragastric balloon system, a non-surgical alternative for the treatment of overweight and obese adults; and OverStitch, an endoscopic suturing system that enables endoscopic procedures by allowing physicians to place full-thickness sutures and secure the approximation of tissue through an Olympus dual-channel flexible endoscope. It also provides surgical products, including Lap-Band system, a system designed to provide minimally invasive long-term treatment of obesity; and accessories used in laparoscopic bariatric surgeries. The company is based in Austin, Texas.
Latest APEN News From Around the Web
Below are the latest news stories about APOLLO ENDOSURGERY INC that investors may wish to consider to help them evaluate APEN as an investment opportunity.
Analysts Are Downgrading These 10 StocksIn this article, we will discuss the 10 stocks recently downgraded by analysts. If you want to see more such stocks on the list, you can directly visit Analysts Are Downgrading These 5 Stocks. Microsoft Corporation (NASDAQ:MSFT) is in the news after the company posted fiscal Q2 results. The company’s revenue outlook for the March […] |
Apollo Endosurgery Announces Two Important Milestones in the Advancement of Endoscopic Procedures for Patients Living with ObesityApollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in minimally invasive medical devices for gastrointestinal and bariatric procedures, announced today that the MERIT trial, published in The Lancet earlier this year(1), was selected as 2022 Top Story in Gastroenterology.(2) Additionally, the American Society for Metabolic and Bariatric Surgery (ASMBS) formally added four Apollo systems to its list of FDA Approved Bariatric Devices |
Boston Scientific's (BSX) New Buyout to Expand its PortfolioBoston Scientific's (BSX) latest buyout is expected to boost its Endoscopy business by adding Apollo Endosurgery's product portfolio, which includes devices used during ELS procedures. |
Bed Bath & Beyond (BBBY) Stock Rebounds After Black Friday WoesBed Bath & Beyond (BBBY) stock is bouncing back on Tuesday after the retail company's shares took a dive Monday on poor Black Friday sales. |
Why Is Otonomy (OTIC) Stock Up 97% Today?Otonomy (OTIC) stock is on the move Tuesday with heavy trading despite a lack of news from the biopharmaceutical company. |
APEN Price Returns
| 1-mo | -0.40% |
| 3-mo | -0.30% |
| 6-mo | 86.98% |
| 1-year | 50.38% |
| 3-year | 384.76% |
| 5-year | 58.18% |
| YTD | -0.60% |
| 2022 | 18.27% |
| 2021 | 147.94% |
| 2020 | 19.30% |
| 2019 | -17.39% |
| 2018 | -38.39% |
Continue Researching APEN
Want to see what other sources are saying about Apollo Endosurgery Inc's financials and stock price? Try the links below:Apollo Endosurgery Inc (APEN) Stock Price | Nasdaq
Apollo Endosurgery Inc (APEN) Stock Quote, History and News - Yahoo Finance
Apollo Endosurgery Inc (APEN) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...